Elevance Health Inc. (ELV) has a consensus analyst rating of Buy, based on 37 analysts covering the stock. Of those, 26 recommend buying, 11 recommend holding, and 0 recommend selling.
The analyst consensus price target for ELV is $382.64, representing a +22.1% upside from the current price of $313.35. Price targets range from a low of $332.00 to a high of $425.00.
